ResMed (BSP:R1MD34) 3-Year EBITDA Growth Rate : 10.40% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ResMed 3-Year EBITDA Growth Rate?

ResMed's EBITDA per Share for the three months ended in Mar. 2024 was R$3.62.

During the past 12 months, ResMed's average EBITDA Per Share Growth Rate was 14.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of ResMed was 76.30% per year. The lowest was 4.10% per year. And the median was 18.95% per year.

Competitive Comparison of ResMed's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, ResMed's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ResMed's 3-Year EBITDA Growth Rate falls into.

ResMed 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

ResMed (BSP:R1MD34) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

ResMed 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ResMed's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (BSP:R1MD34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany RME:Germany RMEA:Germany RME:Germany RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines